a hrefhttps:www.fiercepharma.compharmafierce-pharma-regulatory-tracker-2026-h2 hreflangenRegulatory tracker: FDA sets decision date for Sareptas DMD drugsa

In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.